Sierra Summit Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,282
Closed -$860K 193
2024
Q4
$860K Buy
22,282
+1,115
+5% +$43K 0.17% 75
2024
Q3
$953K Buy
+21,167
New +$953K 0.22% 62